Join the Hyponatremia group to help and get support from people like you.
Hyponatremia News
FDA Medwatch Alert: Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury
ISSUE: Otsuka and FDA notified healthcare professionals of significant liver injury associated with the use of Samsca. In a double-blind, 3-year, placebo-controlled trial in about 1400 patients with...